Record · corpus.blog/posts/01a087e3-7aa9-7347-a01d-e62c92847631

The Weekend Editrix’s Flu & Bivalent Booster Adventures (And Why She Went Through Them)

Some Weekend Reading – Occasional tart thoughts of a grumpy old retired scientist, your humble Weekend Editor. · published 21 November 2022

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at someweekendreading.blog Wayback capture

0blogs citing

First cited: —
Most recent: —
Rank this month: not ranked
Links from this post: 21
Words captured: 2,592

Cited by

No blog we hold has cited this post yet.

Links from this post

Link

Host

https://twitter.com/EricTopol/status/1577727060667047936

twitter.com

https://twitter.com/DelthiaRicks/status/1568858360371625985

twitter.com

https://www.science.org/doi/10.1126/sciadv.add2032

science.org

https://doi.org/10.1126/sciadv.add2032

doi.org

https://www.news-medical.net/news/20220909/All-SARS-CoV-2-variants-neutralized-by-a-potent-new-antibody.aspx

news-medical.net

https://www.science.org/doi/10.1126/sciimmunol.add5446

science.org

https://doi.org/10.1126/sciimmunol.add5446

doi.org

https://www.latimes.com/science/story/2022-09-14/experimental-covid-19-vaccine-may-outsmart-future-coronavirus-variants

latimes.com

https://www.science.org/doi/10.1126/scitranslmed.abq1945

science.org

https://doi.org/10.1126/scitranslmed.abq1945

doi.org

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-biontech-begin-study-combination-vaccine-covid-flu-2022-11-03/

reuters.com

https://www.pfizer.com/news/announcements/pfizer-and-biontech-initiate-phase-1-study-single-dose-mrna-based-combination

pfizer.com

https://investors.modernatx.com/news/news-details/2022/Moderna-Reviews-Clinical-Trial-Programs-Across-Portfolio-at-2022-RD-Day/default.aspx

investors.modernatx.com

https://www.bostonglobe.com/2022/11/21/nation/new-coronavirus-variant-has-taken-over-sparking-concerns-winter-surge/?event=event12

bostonglobe.com

https://www.biorxiv.org/content/10.1101/2022.11.01.514722v1

biorxiv.org

https://doi.org/10.1101/2022.11.01.514722

doi.org

https://www.biorxiv.org/content/10.1101/2022.10.31.514636v1

biorxiv.org

https://www.biorxiv.org/content/10.1101/2022.10.31.514580v2.full

biorxiv.org

https://doi.org/10.1101/2022.10.31.514580

doi.org

https://www.biorxiv.org/content/10.1101/2022.11.17.516898v1

biorxiv.org

https://investors.modernatx.com/news/news-details/2022/Modernas-BA.4BA.5-Targeting-Bivalent-Booster-mRNA-1273.222-Meets-Primary-Endpoint-of-Superiority-Against-Omicron-Variants-Compared-to-Booster-Dose-of-mRNA-1273-in-Phase-23-Clinical-Trial/default.aspx

investors.modernatx.com